|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$26.68 0.00 (0.00%) as of 4:30 Fri 3/4
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
58,918,000 |
| Market
Cap: |
1.57(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$26.68 - $26.68 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2021-03-15 |
4 |
D |
$20.70 |
$27,883 |
D/D |
(1,347) |
12,741 |
|
- |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2021-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,531 |
13,484 |
|
- |
|
| Farfel Gail M |
EVP/Chief Development Officer |
• – – |
2021-03-15 |
4 |
D |
$20.70 |
$38,585 |
D/D |
(1,864) |
14,776 |
|
- |
|
| Farfel Gail M |
EVP/Chief Development Officer |
• – – |
2021-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,156 |
15,318 |
|
- |
|
| Smith Michael P |
EVP, CFO, Treasurer & Sec. |
• – – |
2021-03-15 |
4 |
D |
$20.70 |
$37,384 |
D/D |
(1,806) |
7,023 |
|
- |
|
| Smith Michael P |
EVP, CFO, Treasurer & Sec. |
• – – |
2021-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,218 |
7,585 |
|
- |
|
| Garner Cam L |
Director |
– • – |
2020-11-19 |
4 |
B |
$20.13 |
$161,042 |
I/I |
8,000 |
16,000 |
2.1 |
4% |
|
| Tannenbaum Renee P |
Director |
– • – |
2020-11-17 |
4 |
S |
$20.74 |
$311,066 |
D/D |
(15,000) |
32,872 |
|
8% |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2020-07-02 |
4 |
D |
$29.19 |
$32,518 |
D/D |
(1,114) |
9,118 |
|
- |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2020-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
10,232 |
|
- |
|
| Farfel Gail M |
EVP/Chief Development Officer |
• – – |
2020-05-12 |
4 |
AS |
$28.21 |
$72,584 |
D/D |
(2,573) |
5,048 |
|
-18% |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2020-05-08 |
4 |
B |
$25.45 |
$25,450 |
D/D |
1,000 |
5,913 |
2.74 |
-6% |
|
| Wiggins Mark C |
Director |
– • – |
2020-03-23 |
4 |
B |
$20.48 |
$51,196 |
D/D |
2,500 |
2,500 |
2.39 |
16% |
|
| Farr Stephen J |
President and CEO |
• • – |
2020-03-19 |
4 |
OE |
$10.35 |
$99,991 |
D/D |
9,661 |
65,251 |
|
- |
|
| Farr Stephen J |
President and CEO |
• • – |
2020-03-19 |
4 |
AS |
$18.51 |
$113,964 |
D/D |
(6,158) |
55,590 |
|
29% |
|
| Galer Bradley S. |
EVP/Chief Medical Officer |
• – – |
2020-03-18 |
4 |
B |
$19.69 |
$19,685 |
D/D |
1,000 |
10,015 |
2.74 |
41% |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2020-03-15 |
4 |
D |
$22.01 |
$13,294 |
D/D |
(604) |
4,913 |
|
- |
|
| Sagrolikar Ashish M |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2020-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,032 |
5,517 |
|
- |
|
| Smith Michael P |
EVP, CFO, Treasurer & Sec. |
• – – |
2020-03-15 |
4 |
D |
$22.01 |
$39,244 |
D/D |
(1,783) |
3,199 |
|
- |
|
| Smith Michael P |
EVP, CFO, Treasurer & Sec. |
• – – |
2020-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,595 |
4,207 |
|
- |
|
| Galer Bradley S. |
EVP/Chief Medical Officer |
• – – |
2020-03-15 |
4 |
D |
$22.01 |
$21,724 |
D/D |
(987) |
9,015 |
|
- |
|
| Galer Bradley S. |
EVP/Chief Medical Officer |
• – – |
2020-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,595 |
9,573 |
|
- |
|
| Farfel Gail M |
EVP/Chief Development Officer |
• – – |
2020-03-15 |
4 |
D |
$22.01 |
$26,874 |
D/D |
(1,221) |
7,621 |
|
- |
|
| Farfel Gail M |
EVP/Chief Development Officer |
• – – |
2020-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,657 |
8,317 |
|
- |
|
| Farr Stephen J |
President and CEO |
• • – |
2020-03-15 |
4 |
D |
$22.01 |
$109,170 |
D/D |
(4,960) |
61,748 |
|
- |
|
234 Records found
|
|
Page 2 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
